Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection
-
- Keith S. Kaye
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor
-
- Tanaya Bhowmick
- Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey
-
- Symeon Metallidis
- Department of First Internal Medicine, AHEPA Hospital, Medical School, Aristotle University, Thessaloniki, Greece
-
- Susan C. Bleasdale
- Department of Medicine, University of Illinois College of Medicine, Chicago
-
- Olexiy S. Sagan
- Department of Urology, Regional Clinical Hospital of Zaporizhizhia, Zaporizhizhia, Ukraine
-
- Viktor Stus
- Department of Urology, Dnipropetrovsk Medical Academy of Ministry of Health of Ukraine, Dnipro
-
- Jose Vazquez
- Division of Infectious Diseases, Medical College of Georgia, Augusta University, Augusta
-
- Valerii Zaitsev
- Clinical Studies Department, Bucovinian State Medical University, Chernivtsi, Ukraine
-
- Mohamed Bidair
- San Diego Clinical Trials, San Diego, California
-
- Erik Chorvat
- Department of Urology, Urologicke Oddelenie NSP, Poprad, Slovak Republic
-
- Petru Octavian Dragoescu
- Department of Urology, Craiova Emergency Clinical Hospital, Craiova, Dolj, Romania
-
- Elena Fedosiuk
- Department of Anesthesiology and Intensive Care, Nephrology and Hemocorrection, Brest Regional Hospital, Brest, State Republic of Belarus
-
- Juan P. Horcajada
- Hospital del Mar, Infectious Pathology and Antimicrobials Resaearch Group (IPAR)—Institut Hospital del Mar d’Investigaciones Mèdiques (IMIM), Barcelona, Spain
-
- Claudia Murta
- Department of Infection Control Service, Santa Casa de Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil
-
- Yaroslav Sarychev
- Department of Urology with Forensic Medicine, Ukrainian Medical Stomatological Academy, Poltava, Ukraine
-
- Ventsislav Stoev
- Department of Urology, Mhat Silistra, Silistra, Bulgaria
-
- Elizabeth Morgan
- The Medicines Company, San Diego, California
-
- Karen Fusaro
- Melinta Therapeutics, Parsippany, New Jersey
-
- David Griffith
- The Medicines Company, San Diego, California
-
- Olga Lomovskaya
- The Medicines Company, San Diego, California
-
- Elizabeth L. Alexander
- The Medicines Company, Parsippany, New Jersey
-
- Jeffery Loutit
- The Medicines Company, San Diego, California
-
- Michael N. Dudley
- The Medicines Company, San Diego, California
-
- Evangelos J. Giamarellos-Bourboulis
- Fourth Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Greece
書誌事項
- タイトル別名
-
- The TANGO I Randomized Clinical Trial
収録刊行物
-
- JAMA
-
JAMA 319 (8), 788-, 2018-02-27
American Medical Association (AMA)